Justin Boyd

Biography

 He bring to Beryllium over a decade of research experience in phenotypic profiling, especially in neurobiology. As an entrepreneurial scientist, he is accomplished in the fields of neuroscience, stem cell biology, and drug discovery. The challenge that he hope to address is creating innovation and improved efficiency in drug discovery.  While at Harvard, his lab utilized technology while focusing exclusively on biological relevance in early stage drug discovery in Alzheimer’s disease, ALS and Parkinson’s disease. Prior to establishing his own lab at Harvard, he was a member of the Laboratory of Drug Discovery in Neurodegeneration, the academic drug discovery group of the Harvard NeuroDiscovery Center, where he led their high content screens and quantitative biology platforms. Before Harvard, he spent some time at Evotec developing stem cell based assays for their screening platform following a postdoctoral fellowship in CNS stem cell biology at the NINDS/NIH.

Research Interest

  Neurobiology